Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0VE3U
|
|||
Drug Name |
JT02
|
|||
Indication | Inflammatory bowel disease [ICD-11: DD72; ICD-10: K50-K52] | Phase 2 | [1] | |
Company |
JYANT Technologies Marietta, GA
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | C-X-C motif chemokine 10 (CXCL10) | Target Info | Inhibitor | [1] |
KEGG Pathway | Cytokine-cytokine receptor interaction | |||
Chemokine signaling pathway | ||||
Toll-like receptor signaling pathway | ||||
RIG-I-like receptor signaling pathway | ||||
Cytosolic DNA-sensing pathway | ||||
TNF signaling pathway | ||||
Influenza A | ||||
NetPath Pathway | IL-7 Signaling Pathway | |||
TSLP Signaling Pathway | ||||
TNFalpha Signaling Pathway | ||||
TWEAK Signaling Pathway | ||||
TCR Signaling Pathway | ||||
Panther Pathway | Inflammation mediated by chemokine and cytokine signaling pathway | |||
Pathway Interaction Database | CXCR3-mediated signaling events | |||
Reactome | Chemokine receptors bind chemokines | |||
G alpha (i) signalling events | ||||
WikiPathways | Toll-like receptor signaling pathway | |||
Type II interferon signaling (IFNG) | ||||
Spinal Cord Injury | ||||
GPCR ligand binding | ||||
GPCR downstream signaling | ||||
Regulation of toll-like receptor signaling pathway |
References | Top | |||
---|---|---|---|---|
REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.